COVID-19 Vaccine Prices, Efficacy, and Safety Compared
Humanity will roll out in 2021 an unprecedented vaccine drive to defeat the COVID-19 pandemic and drug companies from the U.S., U.K., China, and Russia are racing to test and manufacture as many doses as possible in the hopes of ending the pandemic.
Here's what we know so far about the leading vaccine candidates that have been administered or are under advanced clinical trials. Quoted prices (two doses) are from the Philippine Senate. Check this page regularly for updates.
Efficacy: 70% on average
Country of origin: UK
This vaccine's biggest selling points are its price and the fact that it can be transported at regular refrigerator temperatures, compared to sub-zero for other vaccines. This makes transporting the vaccine easier.
Efficacy: Up to 95%
Country of Origin: U.S.
Aside from the U.S., the UK, Bahrain, Canada, Saudi Arabia, and Mexico have approved the Pfizer/BioNTech vaccine.
Transporting this vaccine will be a challenge as it requires storage of -70 degrees Celsius. In the U.S., the military set up Operation Warp Speed to ship millions of doses out to hospitals, clinics, pharmacies, and long-term care facilities.
Last December, Foreign Secretary Teodoro Locsin Jr. said the Philippines could've secured Pfizer vaccines in early 2021 had it not been for one government official, whom he said "dropped the ball."
Efficacy: 50% to 90%
Country of Origin: China
According to a Reuters report, data from a late-stage trial in Turkey showed a 91.25% success rate, while researchers in Brazil said its efficacy was between 50% and 90%.
The vaccine from Sinopharm's Beijing affiliate was cleared by Chinese authorities in late December 2020. The efficacy rate of 79.34% based on tests in China compared to 86% based on tests in the UAE, according to Reuters.
President Rodrigo Duterte's guards got vaccinated with the Sinopharm drug, Malacanang said in December.
Price: P3,904 to P4,504
Country of Origin: U.S.
From a biotech startup, Moderna rose to prominence in 2020 owing to its work on a COVID-19 vaccine.
One of its first projects was to try to develop targeted vaccines against various types of cancer, research which is still underway. But Moderna quickly pivoted to addressing viruses and several clinical trials are taking place involving the Zika virus, Epstein-Barr, and others.
Country of Origin: Russia
Russian President Vladimir Putin touted the vaccine as early as August, saying one of his daughters received it.
Russia's health ministry, the state-run Gamaleya research center, and the Russian Direct Investment Fund (RDIF) said the efficacy rate could still improve in future testing.
"No unexpected adverse events were identified as part of the research," it said, though some of those vaccinated suffered short-term effects including fever, weakness, fatigue, and headache.
This story originally appeared on Reportr.World. Minor edits have been made by the Esquiremag.ph editors.